<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 49 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page48.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=49">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 49 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 49</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=49"><img src="../thumb/49.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>18 / 2020-04                                                     Central Nervous System - 1.4.4 / 14.5
   Side-effects: Abnorm. bleed.predom.of skin & mucous membr.  lerg. reacts., hypothyroid., hyperprolactinaem., appet. chang., hyper-  (S5) TABS, 42/1.2/0912, 0914
   (mostly ecchymos.also GI tract/ CNS & eye), SIADH, psych.disords.,   cholesterolaem., incr. suic.ideat./ attempts risk, decr.libido, depend.,   715402-001: 10 mg, 30, R95,00
   allerg. reacts., decr.appetite, hyponatraem.esp.in elderly, CNS effs.,   sex.dysfunct., dizzin., headache, somnol., CNS effs., paronir., movem.   715403-001: 20 mg, 30, R128,59
   convuls., seroton.syndr., extrapyramid. disords.in pts.using neurolept.   disords.incl. extrapyramid.sympt., paraesthes., trem., migraine, con-  Dosage: Adults: Maj.depress.episod: 10 mg as sngl.dly dos. Poss.
   meds., asthen., periph.oed., blurr.vis., ac.glauc., yawn., urin.retent.,   vuls., invol.musc. contract., hyperkines., syncope, coma, fev., hyper-  incr.to max.20 mg dly. depend. on indiv. respons.2-4 wks.necess.for
   sex.dysfunct., hyperprolactinaem. / galactorrh., GI disords., dry mouth,   tens., tachyard., cerebrovasc.spasm, vis. abnorm., mydrias., tinnit.,   antidepress. respons.
   elev.hepat.enzyme, hepatit.poss.assoc. with jaund./liv.fail., sweat.,   palpitat., MI, bradycard., QTc prolongat., Torsade de Point., hot flush.,   Contraindications: Safety & effic.not est.in childr. und.18 yrs.,
   skin rash, photosens. reacts., mydrias.  periph. ischaem., abnorm.bleed., yawn., bronchosp., dyspn., epistax.,   MAOI’s., safety in pregn.& lactat.not est., no info avail.on sev.ren.
   Special precautions: Worsen.depress./emerg. suicide ideat./-  laryngosp., stridor, interstit. lung dis., psych./convers./tong./teeth/   funct. impairm., known QT interv.prolongat./congenit. long QT syndr.,
   behav.risk in maj.depress./other psych./non-psych disords., monit.  mouth/ urin./micturit./bone/eye/card.disords., saliv. hypersecret.,   concom.meds.known to prolong QT interv.
   pts.esp.dur. early ther.& dos.changes for clinic.worsen./ suicid.ideat./  haematochez., pancreatit., ser. liv. events, hyperhidros., skin reacts.  Side effects: Paradox.anx.at start of panic disord treatm., agitat.,
   behav., consid.chang.therapeut. regim/discont.if psych.sympts.occur   incl.sev. cutan. adverse react., alopec., periorbit./periph./fac.oed.,   panic attacks, sleep disords., hostility/ suic.ideat./self harm in childr.,
   which are sev./abrupt in onset/not part of pres.sympts., grad.withdr.,   angioed., photosens., arthralg., myalg., musc. cramps/ weakn./   irritabil., impulsiv., akathis., hypoman., man., cutan.bleed. abnormalit.,
   mania hist., concom.neurolept./ meds. incr.bleed.risk, known tenden.  twitch., osteoarthrit., back/chest/ ear pain, menstr.irreg., atroph.vul-  ecchymos., inappropr.ADH secret., hyponatraem., weight chang., psych.
   to bleed./ predispos.condits./concom.oral anticoags., concom. Li ther.,   vovaginit., gynaecomast., galactorrh., fatig., asthen., malaise, chills.,   disords., CNS effs.incl.seiz., fatig., seroton.syndr., NMS, movem. dis-
   hostility/suicide ideat.& self harm report.in childr., elderly, sev.ren./  hern., decr.meds. toler., injury, vasodilat. proced., discont.sympt. ALT/  ords., accommodat.disturbs., mydrias., abnorm. vis., postur.hypotens.,
   hepat. impairm., treat.for suffic.period to ensure sympt. free, admin.  AST elevat., incr. sweat., incr. IOP/angl.clos.glauc.esp. predispos.   nas.congest., sinusit., flu-like sympts., GI disturbs., abnorm. LFT, incr.
   in ser.CV disords.not studied, epilep., little clinic.exper.with ECT, narr.  pts., signif. weight loss.  sweat., skin reacts., angioed., arthralg./myalg., urin. retent., sex.dys-
   angle glauc., discont. if prolong.elev.liv.funct.abnormalit./seiz. occur.  Warnings and special precautions: Use for long. than 12 wks.  funct., galactorrh., yawn., anaphylact.reacts., pyrex., taste disturbs.,
   Drug interactions: Toxic.of risperdone poss. incr., drug metabol.   for panic disord.not eval., re-eval. dur.longt.use, adeq.contracept.in   tachycard., bradycard., ECG QT prolong.ventric. arrhythm.incl.torsad.de
   inhibit.poss.incr.bioavail.(e.g. cimetidine), drug metabol.induc..  women of childbear.potent., concom.alcoh.not recomm., concom.   point. most.in females with hypokalaem./pre-exist.QT interv.prolong.or
   poss.decr. plasma conc. (e.g. phenytoin), hepat.cytochrome P450   Li/phenytoin, monit.with sumatriptan/ warfar., monit.pts.for emerg.  other card. dis., discontin.sympt.on abrupt withdr.somet. sev. &/ prolong.
   isozyme CYP2D6 respons.for metabol.of debrisoquine & sparteine   SS/NMS S&S, poss. hypoman./man.activat., QTc prolongat.risk fact.,   Special precautions: Worsen.depress./emerg. suic.ideat./-behav.
   enhanc.plasma lev.of concom.meds. metabol.by this isoenzyme.,   switch. from other antidepress./anti-obsess.esp. longt.agents, avoid   risk in maj.depress./ psych. disords., caref.monit.for poss.suic., monit.
   poss. seroton.syndr. with tryptophan, incr.incid.of adverse effs. with   in unstab.epilep., monit.contr. epilep., discont.treatm.if seiz.devel.,   pts. esp.dur.early ther.& dos.chang.for clinic.worsen./ suic.ideat./
   anti-convuls., incr.procyclidine plasma lev.& other anti-cholinergs.  clinic. worsen./ emerg.suic.ideat./behav.risk in maj. depress. disords./  behav., monit.other psych.& non-psych. disords., cons.chang.ther.
                                                              regim./discont.if psych. sympt.occur which are sev./abrupt in onset/
   ZOLID, Novagen [P/S]         other psych./non-psych.disords., monit. pts.esp.dur.early ther.& dos.  not part of pres.sympt., discont.if manic phase enter., mania/hypo-
                                chang., cons. chang.therap. regim./discont.if psych.sympt.occur which
   Sertraline HCl.              are sev./abrupt in onset/not part of pres. sympt., overdos.risk, dos.ta-  man. hist., seiz.developm., control. epilep.but avoid in unstab.epilept.,
   Indications: Maj.depress.disords.such as sngl. episod. & recurr.de-  per.if discont., weak uricosur.eff., incr.bone fract. risk, dis./condits. af-  diab.mellit., concom.meds.known to alt.platel.funct., bleed. disords.
   press., obsess.compuls.dis., panic disord. with/ without agoraphob.  fect. metabol.or haemodynam.respons., recent MI hist./ unstab.heart   hist., concom. electroconvuls.ther., elderly, hepat.insuff., grad.withdr.,
   (S5) TABS, 41/1.2/0584, 0585  dis.not eval., monit.for gluc. fluctuat.S&S esp.diab.pts., glauc./hist.  concom.high dos. cimetidine, monit.INR with concom.warfar., signif.
   711992-001: 50 mg, 30, R107,89  thereof., safety & effic.in paed.pts.other than childr. 13-17 yrs. with   bradycard., rec.ac.MI, uncompensat. HF, correct electrol.disturbs.bef.
   711991-001: 100 mg, 30, R132,95  OCD not est., hostilit./suic. deat./self-harm report. in childr., withdr.  init.ther., withdr.treatm./ request ECG if signs of card.arrhythm.occur.
   Dosage: Admin as sngl.dly.dos.  sympt.with abrupt discont., no clinic.studies with ECT, avoid concom.   Drug interactions: Enhanc.seroton.assoc.effs. with other sero-
   Depress: Init. 50 mg dly. Usual therapeut.dos. 50 mg dly. May be titr.  agents enhanc. serotonerg.neurotransmiss. eff./ meds. alter.platel.  tonerg.meds.& antidepress.with serotonerg.propert., enhanc.effs.
   up in 50 mg increm.at 2 wkly. interv.to 150-200 mg.  funct., bleed.disord.hist., vol. deplet. pts., cons.discont.& init.appropr.  with Li & tryptophan, imipramine & desipramine plasma lev. incr.,
   OCD: Min.effect.dos. 50 mg dly. Incr.above 100 mg dly have no addit.  ther. in case of symptom.hyponatraem., hyponatraem. poss. due to   AUC of metoprol.& selegiline incr., incr. prothromb. time aft.warfar.
   benef. Eff.may be observ. with.7 days with full activ.usual.aft. 2-4 wks.  SIADH/ assoc.with elderly & diurets.
   Panic disord: Minim.recomm.effect.dos: 50 mg dly. Init.25 mg/day   Drug interactions: Pimozide lev.incr., incr.QTc prolongat. &/ ventr.
   incr.to 50 mg/day aft.1 wk.  dysrhythm.risk with other meds. prolong.QTc interv., poss.high.5HT-
   Contraindications: MAOI, safety & effic.in childr. und.18 yrs.not   assoc. S/E incid.with Li, plasma lev.reduc.& incr. phenytoin conc.when   1.4.5   Serotonin and
   est., safety in pregn.& lactat. not est., unstab.epilep., concom.al-  used concom., cert.CNS effs. with sumatriptan, incr.in prothromb.
   coh.not recomm., avoid agents enhanc.serotonerg. neurotransmiss.   time with warfar., signif.chang.in some pharmacokinet. paramet.   noradrenaline
   eg.tryptophan/fenfluramine.  with diazepam & tolbutamide, cimetidine decr. clear., incr.SS/NMS
   Side effects: Seiz., GI disturbs., incr.appet., taste pervers., CNS   risk with serotonerg. meds./ agents impair.seroton. metab./ antip-  re-uptake inhibitors
   effs., tremor, dizzin., headache, paraesthes., twitch., incr.sweat., sex.  sychot./ other dopamine agon., fatal reacts. poss. with MAOIs.,
   dysfunct., menstr.sympt., palpitat., thirst, skin reacts., myalg., psych.  potent.pharmacodynam. interact. with meds.enhanc. serotonerg.   EXSIRA (MDR Listing)
   disords.incl.psychos., fatig., fev., hot flush., back pain, rhinit., phar-  neurotransmiss. eff. e.g.tryptophan/fenfluramine/ fentanyl/ 5-HT   CYMBALTA, Eli Lilly [P/S]
   yngit., vis. abnormalit., tinnit., micturit.disords., extrapyramid. sympt.,   antagon./ St.John’s Wort.  Duloxetine
   Parkinson’s dis.aggrav., withdr.sympt., movem. disords., hyperprolac-  See also MDR page 674.  Indications: Depress.as defin.by DSM IV criter., diabet.periph.
   tinaem., galactorrh., erythem. multiforme, ser.liv.events incl.liv.fail.,   neuropath.pain.
   hypoesthes., hallucinat., anx.  ZYLIN, Zydus [P/S]         (S5) CAPS, 37/1.2/0299, 37/1.2/0301
   Special precautions: Effic.in use more than 12 wks not eval.in   Sertraline HCl.  703911-002: 30 mg, 28, R618,16
   panic disord., re-eval.pt.period.. dur.longt.use, poss.activat. of ma-  Indications: Maj.depress.disords.such as sngl. episod.& recurr.de-  703910-002: 60 mg, 28, R618,16
   nia/hypoman., poss. signif.weight loss, monit.contr.epilep., discont.   press., obsess.compuls.disord., panic disords.with/-out agrophob.  Dosage:
   if seiz.devel., close supervis.of poss.suic./ high risk pts., weak urico-  (S5) TABS, A39/1.2/0596  Depression: Init.& maint.at 60 mg once dly.
   sur.eff., risk/benef.of concom. ECT ther.not est., dis./condits.affect.   708915-001: 50 mg, 30, R101,18  Diabet.periph.neuropath.pain: 60 mg once dly.
   metabol. or haemodynam.respons., not eval./used with recent MI   Dosage: Admin.as sngl.dly.dos.  Contraindications: Pregn.& lactat., sev.hepat. impairm., MAOI ther.,
   hist./unstab.heart dis., ren./liv. impairm., worsen.depress./emerg.  Depress: Init. 50 mg dly. Usual therap.dos: 50 mg dly. May be titr.up   creatinine clear.&lt;30 ml/ min., childr.und.18 yrs.
   suic.ideat./ behav.risk in maj.depress.disords./other psych./ non-  in 50 mg increm.at 2wk.interv. to 150-200 mg.  Side effects: Palpitat.& tachycard., vertigo, ear pain, tinnit., hypo-
   psych.disords., monit.pts.esp.dur.early ther.& dos.chang.for clinic.  OCD: Min.effect.dos. 50 mg dly. Incr.above 100 mg dly have no ad-  thyroid., blurr.vis., mydrias., vis. disturbs., GI disturbs., fatig., rigors,
   worsen./suic., cons.chang. therapeut. regim./discont.if psych.sympt.  dit.benef. Eff.observ.within 7 days with full activ.aft.2-4 wks.or long.  abdom.pain & discomf., feel.abnorm./hot & cold, malaise, gait dis-
   occur which are sev./abrupt in onset/not part of pres. sympt., taper   Panic disord: Init.25 mg/day incr.to 50 mg/day aft.1 wk.  turb., thirst, laryngit., incr./decr.weight, incr.BP, hepat.lab. findings, bld.
   dos.dur.discont., switch.from other antidepress./anti-obsess.esp.  Contraindications: MAOI, hepat./ren.insuff., safety & effic.in chil-  cholester.incr., decr.appetite, dehydrat., musculoskelet. pain, musc.
   long-act.agents, monit.prot.bound meds., concom.warfarin., monit.   dr.&lt;18 yrs.not est., unstab. epilep., safety in pregn.& lactat.not est.  tightn.& twitch., CNS effs., dysgeus., paraesthes., att.disturbs., dys-
   concom. Li-lev., adeq.contracept.in women of childbear. potent., hy-  Side effects: Seiz., incr.prothrom.time with warfar., palpitat., head-  kines., poor quality sleep, myoclon., insomn., anorgasm., decr.libido,
   ponatraem.poss.due to SAIDH/ assoc.with elderly & diurets., hostil./  ache, dizzin., dry mouth, CNS effs.incl. somnol., paraesthes., hy-  anx., sleep disords., agitat., abnorm.dreams, bruxism, disorientat.,
   suic. ideat./ self-harm report.in childr., monit.pts.with extrapyramid.   poesthes., twitch., hyperton., extrapyramid.sympt., Parkinson’s dis.  apathy, nocturia, urin. hesitat./retent., dysur., polyur., decr.urine flow,
   disords., overdos.risk.      aggravat., skin reacts.incl.erythem. multiform., pancreatit., hepatit.,   abnorm.urin.odour, ejaculat.disord.& dysfunct., yawn., throat tightn.,
   Drug interactions: Poss.interact.with other plasma prot.bound   jaund., liv.fail., GI effs.incl.incr.appet., fatig., fev., incr.sweat., hot flush.,   hyperhidros., night sweats, photosens., cold sweat, cont.dermatit.,
   drugs, signific.chang.in some pharmacokinet. paramet.with diaz-  yawn., taste pervers., thirst, myalg., back pain, movem.disords., psy-  hot flush., periph. coldn., orthostat.hypotens., fast.bld.gluc. incr., dis-
   epam & tolbutamide, cimetidine decr.clear., incr.in prothrombin time   chos., sex.dysfunct., menstr. sympt., hyperprolactinaem., glactorrh.,   cont. sympts., supraventric.dysrythm., SIADH, glauc., hepatit., jaund.,
   with warfar., poss.interact.with meds.metabol.by cytochrome P450.  rhinit., pharyngit., abnorm.vis., tinnit., micturit. freq./disords., alter.  anaphylact. reacts., hyponatraem., hyperglycaem., musc. spasm,
                                platel.funct., hyponatraem., SAIDH.  trismus, extrapyramid.disord., restless legs syndr., serotonin syndr.,
   ZOLOFT, Pfizer [P/S] &       Special precautions: Concom.alcoh./agents enhanc.seroton-  seiz., psych. disords., skin rash, angioneurot.oed., Stev.-John. syndr.,
   Sertraline HCl.              erg. neurotransmiss.eg.tryptophan / fenfluramine, poss.activat.of
   Indications: Maj.depress.disords.such as sngl. episod. & recurr.  hypoman/mania, poss.signific.weight loss, monit.control.epilep.&   urticar., hypertens.crisis, gynaecologic. bleed., suicid.ideat./behav.
                                                              Special precautions: Mild to mod.ren.& hepat. impairm., meds.
   depress., obsess. compuls.disord., panic disord. with/without ago-  discont. treatm.if seiz.develop, close supervis.of poss.suicid.pts.,   predomin.metabol.by CYP2D6 syst., concom.CNS act.meds., ma-
   raphob., OCD in childr.13-17 yrs.  weak uricosuric eff., ECT, dis./ condits.affect.metabol.or haemody-  nia hist., seiz. disord. hist., rais.intra-ocul.press./pts.at risk of ac.
   (S5) TABS, [P/S] 32/1.2/0381  nam.respon., recent MI/unstab.heart dis., liv./ren.impairm., worsen.   narr.-angle glauc., suicide risk, monit.bld. press.in hypertens./card.
   868833-002: 50 mg, 30, R436,94  depress./emerg.suic.ideat./-behav.risk in maj.depress./other psych./  dis.pts., substant.alcoh. use, pre-exist.liv.dis., dos.upto 120 mg/
   Dosage: Admin as sngl.dly.dos.  non-psych.disords., monit. pts.esp.dur.early ther.& dos.chang.for clinc.   day have been used but effic.statist.not diff.and advers. event rate
   Depress: Init. 50 mg dly. Usual therap.dos.50 mg dly. May be titr.up   worsen./ suic.ideat./behav., consid.chang. therapeut. regim./discont.  high., discont.sympts.in neonate aft. matern.use near term, excret.
   in 50 mg increm.at 2 wk. interv. to 150-200 mg.  if psych.sympt.occur which are sev./abrupt in onset/not part of pres.   in breast milk, grad. withdr.
   OCD: Adults: Min.effect.dos.50 mg dly. No addit. benef.with incr.above   sympt., taper dos.dur.discont., limit.exper.in switch. of antidepress./  Drug interactions: Plasma clear.decr.by CYP1A2 inhibit., AUC of
   100 mg dly. Eff.poss.observ. with.7 days with full activ.aft.2-4  wks.or long.  anti-obsess.esp.long-act. agents, monit.prothromb.time with concom.  meds.metabol.by CYP2D6 incr., seroton.syndr.with concom.drugs
   Paed.OCD: Childr.13-17 yrs: Init.50 mg/day. May be incr.in 50 mg/  warfar. when ther.init./stop., monit.Li-lev., adeq. contracept., extrapy-  with serotonerg.activ., meds.highly bound to plasma prot.may incr.
   day increm. up to 200 mg as need. Dos.chang. not to occur at interv.  ramid.disords., use for long. than 12 wks.for panic disord.not eval.  free conc.of either meds.
   of less than 1 wk.           Drug interactions: Poss.interact.with other plasma prot.bound
   Panic disord: Minim.effect.recomm.dos.is 50 mg/ day. Init.25 mg/  drugs, signific.chang.in some pharmacokinet. paramet.with diaze-  CYMGEN, (Aspen Pharmacare) Eli Lilly [P/S]
   day incr.to 50 mg/day aft.1 wk.  pam/ tolbutamide, cimetidine decr.clear., incr. prothromb. time with   Duloxetine
   Contraindications: MAOIs incl.linezolid, concom. pimozide, chil-  warfar., poss.high.incid.of 5HT-assoc.S/E with Li.  Indications: Depress.as defin.by DSM IV criter., diabet.periph.
   dr.&lt; 18 yrs with both OCD & maj. depress. disords., ren./hepat.in-  neuropath.pain (DPNP)
   suff., pregn.& lactat.       ZYTOMIL, Pharma Dynamics [P/S]  (S5) CAPS, 41/1.2/1029, 1030
   Side effects: URTI, otit.med., GI disturbs.incl. oesophagitis., neo-  Escitalopram  713705-001: 30 mg, 28, R268,06
   plasm, diab.melit., lymphadenopath., bld.dyscras., hypersens./ al-  Indications: Maj.depress.episodes.  712786-001: 60 mg, 28, R268,06</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page48.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>&nbsp;&nbsp;&nbsp;<a href="page51.html">51</a>&nbsp;&nbsp;&nbsp;<a href="page52.html">52</a>&nbsp;&nbsp;&nbsp;<a href="page53.html">53</a>&nbsp;&nbsp;&nbsp;<a href="page54.html">54</a>
             </td>
             <td width="35%"><a href="page50.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page50.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
